Funding for this research was provided by:
Biomedical Advanced Research and Development Authority (HHSO100200700029C)
Text and Data Mining valid from 2019-05-06
Received: 2 March 2018
Accepted: 25 April 2019
First Online: 6 May 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice. The research and all appropriate documentation were reviewed and approved by the Independent Ethics Committee or the Institutional Review Board (Chesapeake Research Review Inc., Columbia, MD, USA and Western Institutional Review Boards, Puyllup, WA, USA). Written informed consent was obtained from each participant before the performance of any study-specific procedures.
: Not applicable as no individual patient data is reported.
: SB, JM, LC, and MK have nothing to disclose. MH, NS and RK report their organization received funding from the GSK group of companies to complete the work disclosed in this manuscript. MH and NS also report funding from Sanofi or the GSK group of company for activities outside the submitted work. GM was previously an employee of the GSK group of company, and she held shares in the GSK group of companies. TD reports consulting fees to his institution at the time of the study, Keyrus Management SA, from the GSK group of companies. AM, AS, BS and JL are employees of the GSK group of company; AM, AS, and BS hold shares in the GSK group of companies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.